Investment analysts at StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on the software maker’s stock.
Veradigm Trading Down 3.3 %
MDRX opened at $10.39 on Wednesday. The firm has a fifty day moving average price of $9.91 and a 200 day moving average price of $9.70. Veradigm has a 1 year low of $5.01 and a 1 year high of $11.80.
Hedge Funds Weigh In On Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- How to Invest in the Best Canadian Stocks
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Airline Stocks – Top Airline Stocks to Buy Now
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
